Source evidence
Backers
V-Bio Ventures
Active Belgian life sciences VC investing in biotech and drug development companies.
Something wrong or missing? Send an update. Fixed within 24 hours.
D
Protealis Series A
Company's launch release confirms EUR 6m initial capital; the same release calls it both seed financing and Series A.